| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $321.6M | +233.2% |
| Cost of Revenue | $124.9M | +181.5% |
| R&D Expense | $15.5M | +20.9% |
| SG&A Expense | $37.9M | +69.9% |
| Operating Income | -$164.1M | — |
| Pre-tax Income | -$170.5M | -3341.1% |
| Income Tax | $3.5M | +2218.3% |
| Net Income | -$170.5M | -3238.1% |
| EPS (Basic) | -$1.10 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $44.1M | +511.3% |
| Accounts Receivable | $51.1M | +214.9% |
| Inventory | $1.3M | -26.1% |
| Current Assets | $134.9M | — |
| Total Assets | $241.4M | — |
| Current Liabilities | $219.0M | +4779.2% |
| Long-term Debt | $45.5M | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$83.3M | -3547.9% |
| Investing Cash Flow | -$55.6M | -225.5% |
| Financing Cash Flow | $175.8M | +502.5% |
| -71.6% |
| EPS (Diluted) | -$1.10 | -71.6% |
| Total Liabilities |
| $267.2M |
| +2827.4% |
| Stockholders' Equity | -$25.8M | -203.2% |